T1	Outcomes 164 187	safety and tolerability
T2	Outcomes 751 773	frequency and severity
T3	Outcomes 850 876	BCVA and retinal thickness
T4	Outcomes 889 913	dose-limiting toxicities
T5	Outcomes 932 953	ocular adverse events
T6	Outcomes 986 1031	Conjunctival hyperemia, hemorrhage, and edema
T7	Outcomes 1082 1105	conjunctival hemorrhage
T8	Outcomes 1244 1262	Conjunctival edema
T9	Outcomes 1275 1288	visual acuity
T10	Outcomes 1370 1399	serious ocular adverse events
T11	Outcomes 1418 1442	nonocular adverse events
T12	Outcomes 1482 1499	Systemic exposure
T13	Outcomes 1527 1547	blood concentrations
T14	Outcomes 1652 1656	BCVA
T15	Outcomes 1770 1806	median decrease in retinal thickness
T16	Outcomes 1853 1876	median increase in BCVA
T17	Outcomes 2000 2017	retinal thickness